ChinaBio^® Partnering Forum 2021
May 10–14, 2021
ChinaBio^® Partnering Forum, in its new hybrid delivery, enables you to identify, meet and network with leaders across the life science value chain to accelerate your cross-border partnerships and expand your reach into the China market.

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott. Recent 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 Click a link below to view the mailing archive as if it had been sent to you. 2021-01-24 01:30 Week in Review: Suzhou's Adagene to Stage $125 Million IPO on NASDAQ 2021-01-23 01:30 Sinovac to Expand Production of COVID-19 Vaccine to 2 Billion Doses 2021-01-22 01:30 Adagene of Suzhou Files for $125 Million US IPO and more... 2021-01-21 01:30 Immunotech of Beijing In-licenses Immunotherapy from T-Cure and more... 2021-01-20 01:30 Sinovent Completes Pre-IPO Financing of at least $30 Million and more... 2021-01-19 01:30 EdiGene Approved to Start China Trial of Gene-Edited Stem Cell Therapy and more... 2021-01-17 01:30 Week in Review: BeiGene Signs $2.2 Billion Deal with Novartis for PD-1 2021-01-16 01:30 EQRx Raises $500 Million to Develop China-Sourced Drugs for US Market and more... 2021-01-15 01:30 ChinaBio® Report: 2020 China Life Science Investment Hits New Records and more... 2021-01-14 01:30 Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL 2021-01-13 01:30 BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal and more... 2021-01-12 01:30 ChinaBio at JP Morgan: China Biopharma Books Strong 2020, Despite Pandemic and more... 2021-01-10 01:30 Week in Review: China Biopharma Starts 2021 with Over $1 Billion in Deals and IPOs 2021-01-09 01:30 Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies and more... 2021-01-08 01:30 Zai Lab Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal and more... 2021-01-07 01:30 Keya Medical Completes $46 Million Round for AI-based Scanning Software and more... 2021-01-06 01:30 Terns Completes $87 Million Financing to Advance Three NASH Candidates and more... 2021-01-05 01:30 Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park and more... 2021-01-03 01:30 Week in Review: DXY Raises $500 Million for Online Consumer Healthcare Site 2021-01-01 01:30 ImmVira Completes C Round for Oncolytic Virus and Vector Candidates and more... January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June May April March February January December November October September August July June Please enter all required fields Correct invalid entries   Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... Greg B. Scott Executive Editor ChinaBio® Today ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC